A strong leadership team comprised of members with an average of 25 years experience within Tech and MedTech companies. We lead the category with tech development and expertise across VOCs analysis, Miniaturized VOC Sensors, Breath Microfluidics, Algorithms & Machine Learning. Our extensive business experience includes investor exit strategies with a value of €500m+.
Ben Delhey
Chief Executive Officer
Ben Delhey
Chief Executive Officer
Over his 20-year career, Ben has worked in different leading marketing and sales position, primarily in diabetes devices and consumer business at LifeScan, Johnson & Johnson, Bayer and Sanofi. Ben has launched more than 10 diabetes devices and software as a medical device in more than 25 countries world wide, e.g. OneTouch products, MyStar products and My DoseCoach. He was the commercial lead to implement and execute the new diabetes category of algorithm based drug dosing advisors.
Arnaud has experience as a founding CEO of both newly-formed organizations and established companies growing at a rapid pace. He is an expert in the financial challenges faced by companies in high-growth sectors, as well as experience driving high-value investor exit strategies. Arnaud is skilled in working in multinational environments, particularly in the telecommunications, Internet and software industries. He has a degree in civil engineering the Ecole Nationale Supérieure des Mines de Saint-Etienne, as well as an MBA from ESSEC Business School in Paris, France.
Over his 30-year career, Bruno has helped launch and scale some of the world’s most innovative telecommunication products, mobile phones and sensors. As such, he has extensive experience managing investor exit strategies. Before co-founding BOYDSense, Bruno was the Chief Technology Officer at Sensitive Object. He also served as Vice President of R&D at Siemens Mobile Phones, and studied at the Conservatoire National des Arts et Metiers.
With an extensive academic background and 25 years of career research, Sandrine has domain expertise in sensors, nanomaterials, materials chemistry, analytical chemistry, human breath analysis, data mining and artificial intelligence. Her previous experience includes serving as Technical Lead at Merck Prolabo, and completing her post-doctoral studies at Israel’s Weizmann Institute.
Frank is an international operating professional with over 25 years experience in clinical development and medical affairs for innovative drugs and devices and software at Sanofi. Involved in the clinical development of endocrine drugs, semi-invasive and non-invasive glucose monitors, dose guidance systems, M-Health and drug delivery systems. He has also completed intensive work with regulatory agencies in the US and the EU.
PharmD, Head of Quality Assurance & Regulatory Affairs
Dr. Céline Zakari
PharmD, Head of Quality Assurance & Regulatory Affairs
Céline is a highly accomplished result-oriented and patient focused professional with over 25 years experience in Pharmaceutical and MedTech fields. As a specialist in Quality Management Systems & Regulatory Affairs in all types of medical devices, Céline is the Person Responsible for Regulatory Compliance (PRRC). Céline has certificates of Bacteriology and Clinical Pharmacology and a Doctorate of Pharmacy from Faculté de Pharmacie de Clermont-Ferrand. She is also an Expert member of various AFNOR and ISO standardization commissions: Biological and clinical evaluation of medical devices, In vitro diagnostic medical devices, Quality management and general aspects of medical devices.
Anton Kitterlberger and his team built mySugr - a digital service focused on people with diabetes, that has been acquired by Roche in 2017 and is now serving over 2 million users and employs a team of over 170. Through the open service platform, he is well connected through the diabetes and cardiovascular space and is an active startup advisor and Investor.
By submitting your data, you are consenting to receive marketing or communications from us. To understand how we use your data, please read our Privacy Notice.
Sign up to our mailing list
At BOYDSense we believe in the potential of breath analysis to revolutionise health monitoring and management.
Sign up to hear more about our ongoing device, technology and platform development including our latest clinical trials and investment rounds.
By submitting your data, you are consenting to receive marketing or communications from us. To understand how we use your data, please read our Privacy Notice.
We use cookies to analyze site usage. By clicking "Accept", you consent to our use of cookies. You can choose to accept or reject cookies, or adjust your preferences below.
